MUC1 and COVID-19: However, COVID-19 survivors had a significantly lower level of circulating KL-6 than non-survivors (SMD = −1.09; 95%CI: −1.63 to −0.55), and this analysis had low data heterogeneity (p = 0.52, I2 = 0%) [38].